No Data
No Data
Why Appen, Mayne Pharma, Playside, and PYC Shares Are Storming Higher
It has been a tough finish to the week for the S&P/ASX 200 Index (ASX: XJO). In afternoon trade, the benchmark index is down 1.2% to 7,719 points.
Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack
Mayne Pharma Group (ASX:MYX) said a cyberattack on US medical claims clearing house Change Healthcare in February has no material impact on the company as it reiterated its financial guidance for the
Cyberattack Only a Temporary Setback for Mayne Pharma -- Market Talk
0127 GMT - Mayne Pharma keeps its bull at Wilsons, where analysts see impact from a recent U.S. healthcare cyberattack as only a temporary setback. The Wilsons analysts tell clients in a note that the
Mayne Pharma Price Target Cut 4% to A$7.09/Share by Wilsons
Mayne Pharma Price Target Cut 4% to A$7.09/Share by Wilsons
Mayne Pharma Group Limited's (ASX:MYX) Largest Shareholders Are Individual Investors With 38% Ownership, Institutions Own 33%
Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents
Mayne Pharma Group (ASX:MYX) said that the US Patent and Trademark Office has granted patent numbers 11,964,055 and 11,957,694, providing additional protection to the Nextstellis oral contraceptive fo
No Data